SE9903985D0 - Use of nitric oxide - Google Patents

Use of nitric oxide

Info

Publication number
SE9903985D0
SE9903985D0 SE9903985A SE9903985A SE9903985D0 SE 9903985 D0 SE9903985 D0 SE 9903985D0 SE 9903985 A SE9903985 A SE 9903985A SE 9903985 A SE9903985 A SE 9903985A SE 9903985 D0 SE9903985 D0 SE 9903985D0
Authority
SE
Sweden
Prior art keywords
nitric oxide
combination
airway constriction
mammal
medicament
Prior art date
Application number
SE9903985A
Other languages
English (en)
Swedish (sv)
Inventor
Josephine Hjoberg
Goeran Hedenstierna
Marieann Hoegman
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Priority to SE9903985A priority Critical patent/SE9903985D0/xx
Publication of SE9903985D0 publication Critical patent/SE9903985D0/xx
Priority to PL00354653A priority patent/PL354653A1/xx
Priority to EP00980159A priority patent/EP1225913B8/en
Priority to IL14917000A priority patent/IL149170A0/xx
Priority to JP2001534406A priority patent/JP2003513048A/ja
Priority to CNB00815287XA priority patent/CN1230199C/zh
Priority to BR0015329-0A priority patent/BR0015329A/pt
Priority to CZ20021559A priority patent/CZ20021559A3/cs
Priority to HU0203065A priority patent/HUP0203065A3/hu
Priority to CA002389655A priority patent/CA2389655A1/en
Priority to AT00980159T priority patent/ATE302023T1/de
Priority to MXPA02004069A priority patent/MXPA02004069A/es
Priority to DE60022070T priority patent/DE60022070T2/de
Priority to ARP000105779A priority patent/AR026335A1/es
Priority to ES00980159T priority patent/ES2248153T3/es
Priority to AU17456/01A priority patent/AU778347B2/en
Priority to EEP200200240A priority patent/EE200200240A/et
Priority to PCT/SE2000/002153 priority patent/WO2001032202A1/en
Priority to ZA200203391A priority patent/ZA200203391B/en
Priority to NO20022113A priority patent/NO20022113L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9903985A 1999-11-03 1999-11-03 Use of nitric oxide SE9903985D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
HU0203065A HUP0203065A3 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
AT00980159T ATE302023T1 (de) 1999-11-03 2000-11-02 Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
IL14917000A IL149170A0 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
JP2001534406A JP2003513048A (ja) 1999-11-03 2000-11-02 気道狭窄の治療のための酸化窒素の使用
CNB00815287XA CN1230199C (zh) 1999-11-03 2000-11-02 氧化氮用于气道狭窄治疗的用途
BR0015329-0A BR0015329A (pt) 1999-11-03 2000-11-02 Uso de óxido nìtrico para o tratamento de constrição das vias aéreas
CZ20021559A CZ20021559A3 (cs) 1999-11-03 2000-11-02 Použití oxidu dusnatého pro výrobu léku k léčení konstrikce dýchacích cest
PL00354653A PL354653A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
CA002389655A CA2389655A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
EP00980159A EP1225913B8 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
MXPA02004069A MXPA02004069A (es) 1999-11-03 2000-11-02 Uso de oxido nitrico para el tratamiento de construccion de vias aereas.
DE60022070T DE60022070T2 (de) 1999-11-03 2000-11-02 Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
ARP000105779A AR026335A1 (es) 1999-11-03 2000-11-02 Uso del oxido nitrico inhalable en la forma de oxido nitrico gaseoso o de un donante de oxido nitrico, en combinacion con un secuestrante de aniones superoxido para la manufactura de un medicamento y una composicion farmaceutica
ES00980159T ES2248153T3 (es) 1999-11-03 2000-11-02 Uso de oxido nitrico para el tratamiento de la construccion de las vias aereas.
AU17456/01A AU778347B2 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction
EEP200200240A EE200200240A (et) 1999-11-03 2000-11-02 Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks
ZA200203391A ZA200203391B (en) 1999-11-03 2002-04-29 Use of nitric oxide for the treatment of airway constriction.
NO20022113A NO20022113L (no) 1999-11-03 2002-05-02 Bruk av nitrogenoksid for behandling av sammensnöringer i luftveiene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide

Publications (1)

Publication Number Publication Date
SE9903985D0 true SE9903985D0 (sv) 1999-11-03

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide

Country Status (20)

Country Link
EP (1) EP1225913B8 (et)
JP (1) JP2003513048A (et)
CN (1) CN1230199C (et)
AR (1) AR026335A1 (et)
AT (1) ATE302023T1 (et)
AU (1) AU778347B2 (et)
BR (1) BR0015329A (et)
CA (1) CA2389655A1 (et)
CZ (1) CZ20021559A3 (et)
DE (1) DE60022070T2 (et)
EE (1) EE200200240A (et)
ES (1) ES2248153T3 (et)
HU (1) HUP0203065A3 (et)
IL (1) IL149170A0 (et)
MX (1) MXPA02004069A (et)
NO (1) NO20022113L (et)
PL (1) PL354653A1 (et)
SE (1) SE9903985D0 (et)
WO (1) WO2001032202A1 (et)
ZA (1) ZA200203391B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
JP2005533013A (ja) 2002-04-19 2005-11-04 イスム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム 一酸化窒素供与基および反応性酸素種捕捉基を含有するβ作用薬化合物、ならびに呼吸障害の治療における該化合物の使用
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
EP2359845A4 (en) * 2008-12-03 2015-05-27 Ltt Bio Pharma Co Ltd INHALANT COMPRISING A MODIFIED SUPERMEDASE SUPERMEDASE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133584D1 (de) * 1990-12-05 2007-12-13 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefässverengung und von Asthma
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
CN1387441A (zh) 2002-12-25
WO2001032202A1 (en) 2001-05-10
JP2003513048A (ja) 2003-04-08
DE60022070D1 (de) 2005-09-22
IL149170A0 (en) 2002-11-10
EP1225913B1 (en) 2005-08-17
ES2248153T3 (es) 2006-03-16
MXPA02004069A (es) 2003-08-20
NO20022113D0 (no) 2002-05-02
HUP0203065A3 (en) 2006-07-28
PL354653A1 (en) 2004-02-09
BR0015329A (pt) 2002-07-09
CZ20021559A3 (cs) 2003-05-14
ZA200203391B (en) 2002-12-20
AU1745601A (en) 2001-05-14
DE60022070T2 (de) 2006-03-30
NO20022113L (no) 2002-05-02
EE200200240A (et) 2003-06-16
CA2389655A1 (en) 2001-05-10
AU778347B2 (en) 2004-12-02
EP1225913B8 (en) 2005-10-19
ATE302023T1 (de) 2005-09-15
CN1230199C (zh) 2005-12-07
EP1225913A1 (en) 2002-07-31
AR026335A1 (es) 2003-02-05
HUP0203065A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
DE60027921D1 (de) Vorrichtung zur gleichzeitigen verabreichung von gasen und medikamenten
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA05010402A (es) Oxido nitrico en el tratamiento de la inflamacion.
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
ATE339954T1 (de) Kombinationen von formoterol und tiotropium-salz
SE0004229D0 (sv) Inhalation of nitric oxide
DE69535234D1 (de) Mittel zur behandlung der allergischen rhinitis und anderer erkrankungen enthaltend descarboethoxyloratadin
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
HK1084862A1 (en) Use of omega interferon in the manufacturing of a medicament for treating viral disease in a warm-blooded animal subject
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
IL182352A0 (en) The use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
HK1068606A1 (en) Novel aminobenzoephenones
PT1677806E (pt) Métodos para tratamento de entorse e distensão muscular aguda e por excesso de esforço utilizando ácido hialurónico
SE9903985D0 (sv) Use of nitric oxide
JP2003528919A5 (et)
SE9902597D0 (sv) New use
HK1015692A1 (en) Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8, for treating infections
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
JP2001316293A5 (et)
SE9101341D0 (sv) New medicinal use
BR0115610A (pt) Uso de bromelina para o tratamento de doenças inflamatórias e terapia adjuvante durante processos de cura de ferimentos
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
US20060009424A1 (en) Nasaleaze